| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Friday - Jan 14, 2022 |
|||||||||
| Q4 FY21 | $3.33 | $2.98 | $30.71B | $29.82B |
NYSE |
||||
| Q4 FY21 | $1.46 | $1.38 | $18.33B | $18.31B |
NYSE |
||||
| Q4 FY21 | $1.25 | $1.13 | $20.86B | $17.86B |
NYSE |
||||
| Q4 FY21 | $10.42 | $10.23 | $5.11B | $5.16B |
NYSE |
||||
|
TPG
TPG
|
- | $6.73 | - | $741.34M | - |
NASDAQ |
|||
|
Golden Matrix Group
GMGI
|
- | $0.11 | - | $6.55M | - |
NASDAQ |
|||
FingerMotion
FNGR
|
- | -$0.02 | - | $5.90M | - |
NASDAQ |
|||
|
Arcellx
ACLX
|
- | -$0.78 | - | - | - |
NASDAQ |
|||
|
Nuvectis Pharma
NVCT
|
- | -$0.40 | - | - | - |
NASDAQ |
|||
